全球髖關節重建市場 - 市場規模（依細分市場）、佔有率、監管、償付、程序、預測（~2033）

髖關節重建或髖關節置換是一種包括置換髖關節受損或患病部分的手術。髖關節重建的類別包括髖關節置換手術中使用的裝置（植入物）。髖關節置換術是一種常見的手術，以人工髖關節或植入物取代受損的髖關節。髖骨關節炎（OA）和類風濕性關節炎（RA）盛行率的增加以及創傷病例的增加，推動對髖關節置換植入物的需求增加。

本報告研究和分析了全球髖關節重建市場，提供了有關主要參與者和市場佔有率、主要趨勢、創新產品和技術以及競爭格局的資訊。

市場模型的主要內容如下。

已上市的髖關節重建設備和不斷變化的競爭格局

• 對主要產業趨勢的考察
• 依細分市場劃分的髖關節重建設備市場年收入和市場前景（2015-2033年）
• 依細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細資料

全球、區域和國家層面的特定市場考察

• 依地區細分全球趨勢的特定市場定性資訊和國家考察
• 髖關節重建器材市場的SWOT分析
• 髖關節重建器材市場競爭動態的考察與趨勢

掌握包括醫療保健系統概述真實情況，促進市場了解。市場進入部分還提供有關償付政策和監管環境的訊息，能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技監理狀況

目標公司

• Zimmer Biomet Holdings Inc
• DePuy Synthes Inc
• Stryker Corp
• Smith & Nephew Plc
• B. Braun Melsungen AG
• Limacorporate SpA
• MicroPort Scientific Corp
• Medacta Group SA
• Corin Group Ltd
• Exactech Inc
• Kyocera Medical Technologies Inc
• Baumer SA
• Waldemar Link GmbH & Co KG
• Amplitude SA S
• United Orthopedic Corp
• Corentec Co Ltd
• 其他

Hip Reconstruction Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Orthopedic Devices therapeutic area.

Hip Reconstruction or Hip Replacement is a procedure which involves replacement of the damaged or diseased parts of the hip joint. The Hip Reconstruction category includes devices (implants) used in the Hip Replacement procedures. A hip replacement is a common type of surgery where a damaged hip joint is replaced with an artificial one or an implant. The increasing prevalence of osteoarthritis (OA) and rheumatoid arthritis (RA), and the growing number of trauma cases are driving an increased demand for hip replacement implants.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Hip Reconstruction Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Hip Reconstruction Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Hip Reconstruction Devices market.
• Competitive dynamics insights and trends provided for Hip Reconstruction Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Stryker Corp, Smith & Nephew Plc, B. Braun Melsungen AG, Limacorporate SpA, MicroPort Scientific Corp, Medacta Group SA, Corin Group Ltd, Exactech Inc, Kyocera Medical Technologies Inc, Baumer SA, Waldemar Link GmbH & Co KG, Amplitude SA S, United Orthopedic Corp, Corentec Co Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Hip Reconstruction marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Hip Reconstruction market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hip Reconstruction market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Hip Reconstruction market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.